NovoCure (NVCR) News Today $18.97 +0.53 (+2.87%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$18.96 0.00 (-0.03%) As of 03/27/2025 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Teacher Retirement System of Texas Invests $1.77 Million in NovoCure Limited (NASDAQ:NVCR)Teacher Retirement System of Texas acquired a new stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 59,252 shares of the medical equipmentMarch 28 at 4:00 AM | marketbeat.comNovoCure (NASDAQ:NVCR) Shares Down 4.1% - Here's WhyNovoCure (NASDAQ:NVCR) Shares Down 4.1% - What's Next?March 26 at 4:04 PM | marketbeat.comEmerald Advisers LLC Makes New Investment in NovoCure Limited (NASDAQ:NVCR)Emerald Advisers LLC bought a new position in NovoCure Limited (NASDAQ:NVCR - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 547,557 shares of the medical equipment provider's stock, valueMarch 24, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Receives $35.80 Average PT from AnalystsMarch 24, 2025 | americanbankingnews.comSemanteon Capital Management LP Sells 60,453 Shares of NovoCure Limited (NASDAQ:NVCR)Semanteon Capital Management LP lowered its position in NovoCure Limited (NASDAQ:NVCR - Free Report) by 82.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 13,276 shares of the medical equipment provider's stock after sMarch 23, 2025 | marketbeat.comProficio Capital Partners LLC Acquires Shares of 30,158 NovoCure Limited (NASDAQ:NVCR)Proficio Capital Partners LLC acquired a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 30,158 shares of the medical equipment provider's stock, valuedMarch 22, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Receives Consensus Rating of "Moderate Buy" from AnalystsShares of NovoCure Limited (NASDAQ:NVCR - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the five ratings firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have issued a buMarch 21, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Rating Increased to Hold at StockNews.comStockNews.com raised shares of NovoCure from a "sell" rating to a "hold" rating in a report on Tuesday.March 19, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Upgraded to "Hold" at StockNews.comMarch 19, 2025 | americanbankingnews.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Essex Investment Management Co. LLCEssex Investment Management Co. LLC cut its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 24.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 121,826 shares of the medical equipment provider's stock after selling 40,111 shares during the periMarch 10, 2025 | marketbeat.comProficio Capital Partners LLC Takes Position in NovoCure Limited (NASDAQ:NVCR)Proficio Capital Partners LLC bought a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 30,158 shares of the medical equipment provider's stoMarch 9, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) is Nordwand Advisors LLC's 3rd Largest PositionNordwand Advisors LLC decreased its stake in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 89.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 312,155 shares of the medical equipment provider's stock afterMarch 8, 2025 | marketbeat.comWells Fargo Sticks to Its Buy Rating for NovoCure (NVCR)March 6, 2025 | markets.businessinsider.comNovoCure (NASDAQ:NVCR) Downgraded to "Sell" Rating by StockNews.comStockNews.com cut NovoCure from a "hold" rating to a "sell" rating in a research report on Monday.March 4, 2025 | marketbeat.comPrediction: Novocure (NVCR) Will Beat the Market. Here's WhyMarch 4, 2025 | fool.comNovocure to Participate in Leerink Partners 2025 Global Healthcare ConferenceMarch 4, 2025 | finance.yahoo.comHC Wainwright Has Negative View of NovoCure FY2029 EarningsNovoCure Limited (NASDAQ:NVCR - Free Report) - Stock analysts at HC Wainwright lowered their FY2029 earnings estimates for NovoCure in a report issued on Thursday, February 27th. HC Wainwright analyst E. Bodnar now anticipates that the medical equipment provider will earn $0.23 per share for theMarch 3, 2025 | marketbeat.comQ1 Earnings Estimate for NovoCure Issued By Leerink PartnrsNovoCure Limited (NASDAQ:NVCR - Free Report) - Equities research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of NovoCure in a research note issued on Thursday, February 27th. Leerink Partnrs analyst J. Chang expects that the medical equipment provider will earn ($0.4March 3, 2025 | marketbeat.comY Intercept Hong Kong Ltd Takes Position in NovoCure Limited (NASDAQ:NVCR)Y Intercept Hong Kong Ltd acquired a new stake in NovoCure Limited (NASDAQ:NVCR - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 18,769 shares of the medical equipment provider's stock, valued at approMarch 2, 2025 | marketbeat.comNew York State Common Retirement Fund Increases Holdings in NovoCure Limited (NASDAQ:NVCR)New York State Common Retirement Fund raised its holdings in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 201.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 99,595 shares ofMarch 2, 2025 | marketbeat.comLos Angeles Capital Management LLC Acquires 55,334 Shares of NovoCure Limited (NASDAQ:NVCR)Los Angeles Capital Management LLC increased its holdings in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 362.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 70,601 shares of thMarch 1, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Posts Earnings Results, Misses Expectations By $0.27 EPSNovoCure (NASDAQ:NVCR - Get Free Report) issued its earnings results on Thursday. The medical equipment provider reported ($0.61) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.34) by ($0.27). NovoCure had a negative return on equity of 41.48% and a negative net margin of 25.93%.February 28, 2025 | marketbeat.comNovoCure Ltd (NVCR) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Financial ...February 28, 2025 | finance.yahoo.comNovoCure Q4 2024 Earnings: Strong And Growing PipelineFebruary 28, 2025 | seekingalpha.comNovoCure (NASDAQ:NVCR) Shares Gap Down After Earnings MissNovoCure (NASDAQ:NVCR) Shares Gap Down Following Weak EarningsFebruary 28, 2025 | marketbeat.comNovoCure's Expansion Strategy Struggles To Translate Approvals Into GrowthFebruary 28, 2025 | seekingalpha.comNovoCure’s Earnings Call: Growth Amid ChallengesFebruary 28, 2025 | msn.comNovoCure (NVCR) Q4 2024 Earnings Call TranscriptFebruary 27, 2025 | msn.comNovoCure Limited (NVCR) Q4 2024 Earnings Conference Call TranscriptFebruary 27, 2025 | seekingalpha.comNovoCure Q4 EPS Misses, Revenue MatchesFebruary 27, 2025 | fool.comNovoCure Limited 2024 Q4 - Results - Earnings Call PresentationFebruary 27, 2025 | seekingalpha.comNovocure Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company UpdateFebruary 27, 2025 | businesswire.comTaylor Frigon Capital Management LLC Sells 16,604 Shares of NovoCure Limited (NASDAQ:NVCR)Taylor Frigon Capital Management LLC cut its holdings in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 10.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 143,442 shares of the medicalFebruary 27, 2025 | marketbeat.comC WorldWide Group Holding A S Raises Position in NovoCure Limited (NASDAQ:NVCR)C WorldWide Group Holding A S grew its holdings in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 19.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 621,784 shares of the medical equipment provider'February 24, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Given Average Recommendation of "Moderate Buy" by BrokeragesNovoCure Limited (NASDAQ:NVCR - Get Free Report) has been given an average recommendation of "Moderate Buy" by the six brokerages that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation tFebruary 24, 2025 | marketbeat.comLuxury hotels group Firmdale has sold 20% stake to Swedish pharma tycoonFebruary 20, 2025 | msn.comNovoCure (NVCR) Projected to Post Earnings on ThursdayNovoCure (NASDAQ:NVCR) will be releasing earnings before the market opens on Thursday, February 27. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=656002)February 20, 2025 | marketbeat.comNovoCure Limited (NASDAQ:NVCR) Shares Sold by Baillie Gifford & Co.Baillie Gifford & Co. trimmed its holdings in NovoCure Limited (NASDAQ:NVCR - Free Report) by 30.0% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,161,310 shares of the medical equipment provider's stock afFebruary 18, 2025 | marketbeat.comLegato Capital Management LLC Has $1.09 Million Stock Holdings in NovoCure Limited (NASDAQ:NVCR)Legato Capital Management LLC decreased its position in NovoCure Limited (NASDAQ:NVCR - Free Report) by 34.4% during the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 36,460 shares of the medical equipment provider's stock after selling 19,107 sharFebruary 13, 2025 | marketbeat.comNovocure Rings the Opening BellFebruary 10, 2025 | nasdaq.comJim Cramer on NovoCure Limited (NVCR): ‘I Have Watched Them For Years And Years And They’re Not Making Money’January 30, 2025 | msn.comNovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of NovoCure Limited (NASDAQ:NVCR - Get Free Report) have been given an average recommendation of "Moderate Buy" by the six research firms that are covering the company, Marketbeat.com reports. Two analysts have rated the stock with a hold rating and four have issued a buy rating on the comJanuary 30, 2025 | marketbeat.comExchange Traded Concepts LLC Sells 19,616 Shares of NovoCure Limited (NASDAQ:NVCR)Exchange Traded Concepts LLC decreased its position in shares of NovoCure Limited (NASDAQ:NVCR - Free Report) by 40.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 28,811 shares of the medicJanuary 29, 2025 | marketbeat.comNovoCure (NASDAQ:NVCR) Share Price Crosses Above 50 Day Moving Average - Here's WhyNovoCure (NASDAQ:NVCR) Share Price Crosses Above 50 Day Moving Average - Should You Sell?January 25, 2025 | marketbeat.comNovocure opens new global headquarters in SwitzerlandJanuary 22, 2025 | markets.businessinsider.comNovocure Inaugurates New Global Headquarters in Canton of Zug, SwitzerlandJanuary 22, 2025 | businesswire.comNovoCure (NVCR) Gets a Buy from Piper SandlerJanuary 22, 2025 | markets.businessinsider.comInvesting in NovoCure (NASDAQ:NVCR) a year ago would have delivered you a 85% gainJanuary 22, 2025 | finance.yahoo.comHC Wainwright Analysts Boost Earnings Estimates for NovoCureNovoCure Limited (NASDAQ:NVCR - Free Report) - Research analysts at HC Wainwright boosted their FY2024 EPS estimates for NovoCure in a research note issued to investors on Tuesday, January 14th. HC Wainwright analyst E. Bodnar now expects that the medical equipment provider will post earnings ofJanuary 17, 2025 | marketbeat.comHC Wainwright Estimates NovoCure FY2029 EarningsNovoCure Limited (NASDAQ:NVCR - Free Report) - Equities researchers at HC Wainwright issued their FY2029 earnings per share (EPS) estimates for NovoCure in a research note issued on Tuesday, January 14th. HC Wainwright analyst E. Bodnar anticipates that the medical equipment provider will post eaJanuary 16, 2025 | marketbeat.com Remove Ads Get NovoCure News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter. Email Address NVCR Media Mentions By Week NVCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NVCR News Sentiment▼1.030.78▲Average Medical News Sentiment NVCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NVCR Articles This Week▼75▲NVCR Articles Average Week Remove Ads Get NovoCure News Delivered to You Automatically Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Stevanato Group News Glaukos News Bausch + Lomb News Inspire Medical Systems News Inari Medical News iRhythm Technologies News PROCEPT BioRobotics News Envista News TransMedics Group News Enovis News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NVCR) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovoCure Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NovoCure With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NVCR Stock Free NVCR Stock Alerts